ovarian cancer – Page 4 – Communicable Diseases Research

Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection

난소암과 관련된 동반 질환 및 염증 및 SARS-CoV-2 감염에 대한 영향

Review

Published on 2021-02-252022-09-12
Journal: Journal of Ovarian Research [Category] MERS, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age aldosterone among others androgen angiotensin Cancer patients caused cellular Characteristics chemokine chemokines chronic inflammation colony-stimulating factor comorbid condition comorbid conditions Comorbidities Comorbidity condition contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 symptoms Cytokines death develop disease dysregulated early stage G-CSF gonadotropin granulocyte granulocyte colony-stimulating factor greater Hormones Hospitalization hospitalizations IL-10 IL-2 IL-6 Immunocompromised Increased Infection Inflammation Inflammatory cytokine Inflammatory cytokines interferon involved IP-10 M-CSF Macrophage macrophage colony-stimulating factor MCP-1 mechanism microenvironment molecular monocyte monocyte chemoattractant protein-1 Necrosis organs outcome ovarian cancer Pathogenesis Patient pro-inflammatory Protein public health RAAS Renin renin-angiotensin-aldosterone system risk risk factor SARS-CoV-2 SARS-COV-2 infection sera Severe case severe cases significantly subject TNF-α Tumor tumor necrosis tumor necrosis factor tumor necrosis factor α upregulation vulnerable population women
[DOI] 10.1186/s13048-021-00787-z PMC 바로가기 [Article Type] Review

Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China

Review

Published on 2021-02-182022-10-30
Journal: Journal of Ovarian Research [Category] COVID-19, MERS,

COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

Review

Published on 2021-02-082022-10-30
Journal: Journal of Ovarian Research [Category] COVID-19, MERS,

[키워드] aspecific Cell-mediated immunity chronic inflammation clinical manifestations coagulation disorders Corticosteroids COVID-19 cytokine Cytokine storm Cytokine storm syndrome death defined demonstrated Disease model disease stages driving early diagnosis effective endothelial damage event highlight hypercoagulability Hyperinflammatory hyperinflammatory cytokine storm Immune status immunopathology impair IMPROVE Improving induce Inflammation interleukin-6 laboratory data mechanism multi-organ failure outcome ovarian cancer oxidative stress Pathogenesis Patient patients with COVID-19 Prognosis protocol resistance severe COVID-19 Severe COVID-19 Infection severe disease Specific T-cell response Spread systemic effect systemic symptoms thrombosis tissue Tolerance Treatment treatment approach underlying disease
[DOI] 10.1186/s13048-021-00772-6 PMC 바로가기 [Article Type] Review

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Article

Published on 2021-02-012023-07-12
Journal: Gynecologic oncology [Category] SARS,

[키워드] coping coronavirus COVID-19 ovarian cancer
[DOI] 10.1016/j.ygyno.2020.11.017 PMC 바로가기

Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID‐19 infection

Original Article

Published on 2021-01-212022-10-30
Journal: MedComm [Category] COVID-19,

Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro

세포성 폴리(ADP-리보스) 중합효소 억제제인 스테노파립, 시험관 내에서 SARS-CoV-2 및 HCoV-NL63 인간 코로나바이러스 복제 차단

Research Article

Published on 2021-01-192022-09-10
Journal: mBio [Category] 신약개발, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition approval approved arsenal block Calu Calu-3 caused cell entry cells clinical trial Concentration coronavirus coronavirus disease Coronavirus disease 2019 Coronaviruses COVID-19 death determined by dosage dose-dependent downstream drug drug combination effective evaluated exhibit experiments facilitate growth HCoV-NL63 Human human lung impede in vitro Infection inhibit inhibitor inhibitory kidney lung adenocarcinoma New NL63 ovarian cancer pandemic PARP polymerase Protective Remdesivir repurposing respiratory Respiratory Coronavirus SARS-CoV-2 severe acute respiratory syndrome Coronavirus Spread Stage stenoparib suppressed synergistic synergistic effect the SARS-CoV-2 therapy Treatment Vaccine Vero E6 Viral viral replication
[DOI] 10.1128/mBio.03495-20 PMC 바로가기 [Article Type] Research Article

Advances in ovarian cancer, from biology to treatment

Comments & Opinion

Published on 2021-01-132022-10-05
Journal: Nature cancer [Category] 바이오마커,

[키워드] advance ovarian cancer Treatment
[DOI] 10.1038/s43018-020-00166-5 [Article Type] Comments & Opinion

Gynecological cancers and the global COVID-19 pandemic

Review

Published on 2020-12-042022-10-30
Journal: Journal of the Turkish German Gynecological Association [Category] COVID-19,

[키워드] Affect Asymptomatic CA-125 Cancer cancers Cervical Chemotherapy Chest Computerized tomography concerning contrast medium coronavirus COVID-19 COVID-19 pandemic database debate detect diagnosed Diagnosis early stage Elective surgery Endometrial Cancer Guidance gynecological cancer Health lesion lung lesions management Middle East oncology outpatient clinic ovarian ovarian cancer Patient performed Pregnancy Radiotherapy recommendation reduced resource respiratory searched serum stages suction the patient therapy treated Treatment treatment approach Treatment protocol vaginal cancer vegetation women
[DOI] 10.4274/jtgga.galenos.2020.2020.0119 PMC 바로가기 [Article Type] Review

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic

Article

Published on 2020-12-012023-06-19
Journal: European journal of medical genetics [Category] MERS,

[키워드] Breast cancer COVID-19 Genetic counseling Genetic testing Hereditary breast and ovarian cancer syndrome ovarian cancer
[DOI] 10.1016/j.ejmg.2020.104098 PMC 바로가기

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Original Research

Published on 2020-11-182022-10-31
Journal: Cancer Medicine [Category] COVID-19, MERS, SARS,